Corticosteroids Modulate the Expression of the PKC-anchoring Protein RACK-1 and Cytokine Release in THP-1 Cells
Overview
Authors
Affiliations
We demonstrated that cortisol reduces the expression of RACK-1 (Receptor for Activated C Kinase-1), a protein required for immune cell activation. The aim of this study was to evaluate whether and to what extent other clinically relevant corticosteroids may modulate RACK-1 expression. We used the human promyelocytic cell line THP-1 to investigate the effects of cortisol, prednisone, prednisolone, budesonide, betamethasone and methylprednisolone on RACK-1 expression and cytokine production. As anticipated, all corticosteroids inhibited at non-cytotoxic concentrations in a dose and time related manner LPS-induced TNF-α and IL-8 release, with budesonide, betamethasone and methylprednisolone being the most active followed by prednisolone, cortisol and prednisone. To a similar extent, all corticosteroids also reduced RACK-1 mRNA expression and RACK-1 protein levels as assessed by Real Time PCR and Western blot, respectively. Prednisone was the least potent compound while betamethasone and methylprednisolone where the most active. A good correlation was observed between RACK-1 mRNA or protein levels and cytokine release (Pearson r=0.7376, p=0.0471 for RACK-1 mRNA and TNF-α release, and Pearson r=0.8108, p=0.0252 for RACK-1 protein and IL-8 release). Mifepristone, a potent glucocorticoid receptor (GR) antagonist, completely prevented the effect of cortisol, demonstrating that RACK-1 downregulation is via GR. Furthermore, to by-pass the defective PKC activation due to the decrease in RACK-1, we used a RACK-1 pseudosubstrate, that directly activates PKC-beta. RACK-1 pseudosubstrate was able to restore LPS-induced cytokine production affected by cortisol, supporting the role of RACK-1 in the anti-inflammatory effect of corticosteroids. These results confirm the involvement of RACK-1 in immune cell activation and identify this protein as a novel transcriptional target of corticosteroid-induced anti-inflammatory effects.
Buoso E, Masi M, Limosani R, Oliviero C, Saeed S, Iulini M J Xenobiot. 2025; 15(1.
PMID: 39846545 PMC: 11755641. DOI: 10.3390/jox15010013.
Effects of Bisphenols on RACK1 Expression and Their Immunological Implications in THP-1 Cells.
Buoso E, Kenda M, Masi M, Linciano P, Galbiati V, Racchi M Front Pharmacol. 2021; 12:743991.
PMID: 34621174 PMC: 8490885. DOI: 10.3389/fphar.2021.743991.
Filho E, da Silva E, Ong H, Swaim W, Ambudkar I, Oliver C J Cell Sci. 2021; 134(9).
PMID: 34550354 PMC: 8380048. DOI: 10.1242/jcs.252585.
Yu Y, Wu Y, Yan H, Xia Z, Wen W, Liu D Pharm Biol. 2021; 59(1):1286-1293.
PMID: 34517734 PMC: 8451635. DOI: 10.1080/13880209.2021.1974059.
Corsini E, Buoso E, Galbiati V, Racchi M Adv Exp Med Biol. 2021; 1275:151-163.
PMID: 33539015 DOI: 10.1007/978-3-030-49844-3_6.